News
06/15/2021
NCI Tech Opportunities Webinar: New HIV Vaccine to Treat and Prevent HIV
TTC is planning a technology opportunities webinar on July 13, 2021 from 11:00 am – noon, EST. Attendees will hear from the NCI’s Dr. Genoveffa Franchini about a new HIV vaccine with the potential to prevent HIV infection and treat HIV. The effectiveness of the new vaccine results from deletion of the V1 region from …
06/15/2021
CareTaker Medical and Embody Named to MedTech Innovator Top 50 Startups
MedTech Innovator, the largest accelerator of medical device companies in the world, selected 50 companies to participate in the organization’s flagship four-month Showcase and Accelerator program, featuring the industry’s most transformative device, diagnostic, and digital health technologies from around the globe. These up-and-coming startups will receive unparalleled visibility and access to leading manufacturers, providers, investors, …
06/10/2021
Understanding Barcode Verifier Discrepancies
An ISO compliant, recently recalibrated barcode verifier is arguably the best and only effective defense against barcode quality-related liability. What about barcode verifier discrepancies? There are two types of verifier discrepancies: • Inconsistency of a single verifier • Inconsistency between two or more verifiers This article focuses on the second type. A familiar scenario in …
06/09/2021
NIH Awards Vibrent Health Contract to Create a New Paradigm for Pandemic Preparedness and Response
The National Institutes of Health’s (NIH) National Cancer Institute (NCI) has awarded Vibrent Health, a digital health technology company powering the future of precision health research, the second phase of a contract to validate COVID-CARE, a digital health solution for pandemic response. The web and mobile application will enable fast and accurate screening, automated test …
06/08/2021
GPB Scientific Gets $18M Infusion
As reported online by Richmond BizSense, GPB Scientific closed on an $18 million funding round. The money will help the company roll out its Curate cell processing system, which separates and extracts cells from blood samples to create therapies for cancer and other diseases. Funding came by way of Amgen Ventures and Vensana Capital (firms …
06/08/2021
ReAlta Life Sciences Receives $3.2 Million Grant from Virginia Catalyst to Accelerate Trial for the Treatment of Acute Lung Injury Due to COVID-19
ReAlta Life Sciences has received a $3.2 million grant award from The Virginia Catalyst, also known as the Virginia Biosciences Health Research Corporation (VBHRC), to accelerate the Company’s Phase 1b clinical trial evaluating RLS-0071 for the treatment of acute lung injury (ALI) due to COVID-19. The award, which is granted to Virginia companies to support …